AIM IMMUNOTECH INC. Equity Securities, FV-NI, Realized Gain (Loss)
AIM IMMUNOTECH INC. (AIM) reported Equity Securities, FV-NI, Realized Gain (Loss) of $18.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiRealizedGainLoss · last filed 2026-08-07
- AIM IMMUNOTECH INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2024-06-30 was -$198.00K.
- AIM IMMUNOTECH INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2024-03-31 was -$20.00K.
- AIM IMMUNOTECH INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2023-12-31 was -$46.00K.
- AIM IMMUNOTECH INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2023-09-30 was -$42.00K.
- AIM IMMUNOTECH INC. equity securities, fv-ni, realized gain (loss) for fiscal 2023 was -$176.00K.
- AIM IMMUNOTECH INC. equity securities, fv-ni, realized gain (loss) for fiscal 2022 was -$751.00K.
| Period end | Equity Securities, FV-NI, Realized Gain (Loss) 3 month | Equity Securities, FV-NI, Realized Gain (Loss) 6 month | Equity Securities, FV-NI, Realized Gain (Loss) 9 month | Equity Securities, FV-NI, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-06-30 | $18.00K 10-Q · filed 2026-08-07 | |||
| 2024-06-30 | -$198.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$218.00K 10-Q · filed 2024-08-14 | -$264.00K derived: sum of 3 quarters · filed 2024-08-14 | -$306.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2024-03-31 | -$20.00K 10-Q · filed 2024-05-15 | -$66.00K derived: sum of 2 quarters · filed 2024-05-15 | -$108.00K derived: sum of 3 quarters · filed 2024-05-15 | -$108.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-12-31 | -$46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$88.00K derived: sum of 2 quarters · filed 2024-04-01 | -$88.00K derived: sum of 3 quarters · filed 2024-08-14 | -$176.00K 10-K · filed 2024-04-01 |
| 2023-09-30 | -$42.00K 10-Q · filed 2023-11-14 | -$42.00K derived: sum of 2 quarters · filed 2024-08-14 | -$130.00K 10-Q · filed 2023-11-14 | -$282.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$87.00K 10-Q · filed 2024-08-14 | -$240.00K derived: sum of 3 quarters · filed 2024-08-14 | -$255.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$87.00K 10-Q · filed 2024-05-15 | -$240.00K derived: sum of 2 quarters · filed 2024-05-15 | -$255.00K derived: sum of 3 quarters · filed 2024-05-15 | -$819.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$168.00K derived: sum of 2 quarters · filed 2024-04-01 | -$732.00K derived: sum of 3 quarters · filed 2024-04-01 | -$751.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$15.00K 10-Q · filed 2023-11-14 | -$579.00K derived: sum of 2 quarters · filed 2023-11-14 | -$598.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$564.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$583.00K 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | -$19.00K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |